The genetics of inflammatory bowel disease
The therapy of constipation
Acid suppression in the management of gastro-oesophageal reflux disease—an appraisal of treatment options in primary care
Guidelines for adults on self-medication for the treatment of acute diarrhoea
Abnormal bone turnover in long-standing Crohn’s disease in remission
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes
The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan
Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis
Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled study
Fish oil (Eicosapen) is less effective than metronidazole, in combination with pantoprazole and clarithromycin, for Helicobacter pylori eradication
Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease
Pioglitazone, a specific PPAR-γ ligand, inhibits aspirin-induced gastric mucosal injury in rats
Involvement of cyclooxygenase-2 in hyperplastic gastritis induced by Helicobacter pylori infection in C57BL/6 mice